Distribution of lymph node metastasis and prognosis in duodenal bulb tumors: A multicenter retrospective study.

K Kazuhiko Hisaoka (Department of Surgery, Keio University School of Medicine, Tokyo, Japan) S Satoru Matsuda (Department of Surgery, Keio University School of Medicine, Tokyo, Japan) H Hirofumi Kawakubo (Department of Surgery, Keio University School of Medicine, Tokyo, Japan) M Masashi Takeuchi (Department of Surgery, Keio University School of Medicine, Tokyo, Japan) T Takeyuki Wada (Gastric Surgery Division, National Cancer Center Hospital, Tokyo, Japan) S Shigeki Sekine (Department of Pathology, Keio University School of Medicine, Tokyo, Japan) T Takeshi Takamoto (Department of Hepatobiliary Surgery, National Cancer Center Hospital, Tokyo, Japan) M Mai Tsutsui (Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan) M Masahiro Yura (Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, Japan) H Hiroki Ishida Y Yoshihiro Ono (Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan) S Satoshi Kamiya (Department of Surgery, Keio University School of Medicine, Tokyo, Japan) E Etsuro Bando S Souya Nunobe (Department of Gastroenterological Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan) T Takahiro Kinoshita (Department of Gastric Surgery, National Cancer Center Hospital East, Tokyo, Japan) Y Yuko Kitagawa

Abstract

797 Background: Duodenal tumors, especially duodenal bulb tumors, is a relatively rare malignancy of the gastrointestinal tract. The optimal surgical procedure for primary duodenal tumors has not been established because of its low incidence. The purpose of this study was to examine the distribution of lymph node (LN) metastasis in duodenal bulb tumors. Specifically, in T1a and T1b tumors, we aimed to evaluate the feasibility of distal gastrectomy with duodenal bulb resection combined with lymphadenectomy of regional gastric LNs. Methods: Data from patients who underwent surgery for either adenocarcinoma or neuroendocrine tumor located in the duodenal bulb between 2000 and 2020 were retrospectively analyzed from five high-volume centers in Japan. Patient background, clinicopathological factors, type of surgery, distribution of LN metastasis, and long-term outcomes were evaluated. Results: Of the 128 patients evaluated, LN metastasis was observed in 36%. The frequency of LN metastasis in T1b was 18%. Metastatic LNs were identified in #3, #5, #6, #8a, #8p, #12a, and #13 in T1b. The distribution of LN metastasis in T1b was similar between adenocarcinoma and neuroendocrine tumors. The 3 years overall survival rate in T1a, T1b, and T2–4 was 100%, 93%, and 64%, respectively. ln T1b, while there were three patients with a recurrence, two cases were observed in distant organs without regional LNs, and one patient who underwent pancreaticoduodenectomy had metastasis in the gastric regional LNs. Conclusions: Based on the distribution of LN metastasis with pT1, distal gastrectomy with duodenal bulb resection and regional LN dissection is considered a curative treatment. Conversely, pancreaticoduodenectomy is recommended in tumors with T2 or deeper.

Article Details

Volume / Issue Vol. 43, Issue 4_suppl
Published February 01, 2025
Pages 797-797
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (16)

K

Kazuhiko Hisaoka

Department of Surgery, Keio University School of Medicine, Tokyo, Japan

S

Satoru Matsuda

Department of Surgery, Keio University School of Medicine, Tokyo, Japan

H

Hirofumi Kawakubo

Department of Surgery, Keio University School of Medicine, Tokyo, Japan

M

Masashi Takeuchi

Department of Surgery, Keio University School of Medicine, Tokyo, Japan

T

Takeyuki Wada

Gastric Surgery Division, National Cancer Center Hospital, Tokyo, Japan

S

Shigeki Sekine

Department of Pathology, Keio University School of Medicine, Tokyo, Japan

T

Takeshi Takamoto

Department of Hepatobiliary Surgery, National Cancer Center Hospital, Tokyo, Japan

M

Mai Tsutsui

Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan

M

Masahiro Yura

Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, Japan

H

Hiroki Ishida

Y

Yoshihiro Ono

Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

S

Satoshi Kamiya

Department of Surgery, Keio University School of Medicine, Tokyo, Japan

E

Etsuro Bando

S

Souya Nunobe

Department of Gastroenterological Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

T

Takahiro Kinoshita

Department of Gastric Surgery, National Cancer Center Hospital East, Tokyo, Japan

Y

Yuko Kitagawa